Vanda Pharmaceuticals holds a market capitalization of approximately $318 million, driven by fluctuating share prices hovering around $5.28. Its overall corporate valuation changes dynamically during active market trading sessions based on investor sentiment, quarterly earnings disclosures, cash burn metrics, and commercial performance updates across its core pharmaceutical product lines.